Journal of Medicinal Chemistry · 2012 · 302 citations · 41 references
PharmacyPharmacokineticsPharmacologyDrug DeliveryDrug DesignDrug DiscoveryBlood-brain Barrier BiologyBlood-brain Barrier DeliveryBlood-brain Barrier PenetrationBlood-brain Barrier PharmacologyCerebral Blood FlowBlood-brain Barrier PermeabilityBrain ExposureBrain PermeabilityBrain-to-plasma RatioFraction Unbound DrugPharmacokinetics At The Blood-brain BarrierUnbound Brain ConcentrationUnbound Fraction
This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs. Key parameters for brain penetration are discussed, including unbound brain concentration, unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters. Results from a retrospective analysis of 32 Pfizer CNS clinical drug candidates are described. Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified. Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, respectively. Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.
41
Angela C. Doran, R. Scott Obach, Bill J. Smith et al. · Drug Metabolism and Disposition · 2004 · 440 citations
In vitro models for the blood–brain barrier
Per Garberg, Marguerite Ball, Natalia Borg et al. · Toxicology in Vitro · 2004 · 395 citations
Pharmacy, Neuroscience, Pharmacology +14